Drugs by condition
Drugs approved for nausea and vomiting
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
21
Still marketed, NDA or BLA
Drug classes
8
Novel drugs
10
New molecular entities and new biologics
In development
3
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for nausea and vomiting.
- Navitrux (Fosaprepitant Dimeglumine) · Avyxa Holdings Jun 24, 2026
- Focinvez (Fosaprepitant Dimeglumine) · Steriscience Aug 22, 2023
- Aponvie (Aprepitant) · Heron Theraps INC NovelSep 16, 2022
- Barhemsys (Amisulpride) · Lxo Ireland NovelFeb 26, 2020
- Fosaprepitant Dimeglumine (Fosaprepitant Dimeglumine) · Teva Pharms USA Sep 5, 2019
All approved drugs for nausea and vomiting, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 177 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Substance P/Neurokinin-1 Receptor Antagonist (5)
Aromatic Amino Acid Decarboxylation Inhibitor (2)
Dopamine-2 Receptor Antagonist (1)
- Barhemsys Amisulpride · Lxo Ireland · 2020
Cannabinoid (1)
- Marinol Dronabinol · Alkem Labs LTD · 1985
Aminosalicylate (1)
- Azulfidine En-Tabs Sulfasalazine · Pfizer · 1950
Serotonin-3 Receptor Antagonist (1)
- Sancuso Granisetron · Apotex · 2008
Anticholinergic (1)
- Transderm Scop Scopolamine · Baxter Hlthcare Corp · 1979
Class not listed in FDA's data (9)
- Varubi Rolapitant Hydrochloride · Tersera · 2015
- Emend Fosaprepitant Dimeglumine · Merck and CO INC · 2008
- Navitrux Fosaprepitant Dimeglumine · Avyxa Holdings · 2026
- Focinvez Fosaprepitant Dimeglumine · Steriscience · 2023
- Fosaprepitant Dimeglumine Fosaprepitant Dimeglumine · Teva Pharms USA · 2019
- Bonjesta Doxylamine Succinate, Pyridoxine Hydrochloride · Duchesnay · 2016
- Posfrea Palonosetron Hydrochloride · Avyxa Holdings · 2016
- Diclegis Doxylamine Succinate, Pyridoxine Hydrochloride · Duchesnay · 2013
- Tigan Trimethobenzamide Hydrochloride · Ph Health · 1974
Drugs in development for nausea and vomiting
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- HR20013Phase 31 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
- HRS5580Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Prevention of Postoperative Nausea and Vomiting
- Reference : ondansetronPhase 21 trial
Helsinn Healthcare SA · Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy
4 discontinued brand-name drugs whose label still names it
More on nausea and vomiting: recruiting trials · published research
Related in gastroenterology and liver: MASH (fatty liver disease) · Primary biliary cholangitis · Acid reflux (GERD) · Irritable bowel syndrome · Chronic constipation · Eosinophilic esophagitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.